Motapizone (NAT 05-239) is a selective PDE3 inhibitor that not only moderately reduces cytokine release in lipopolysaccharide (LPS)-stimulated alveolar macrophages but also suppresses human platelet aggregation by elevating intracellular cAMP levels [1]
Molecular Weight:
260.31
CAS Number:
[90697-57-7]
Formula:
C12H12N4OS
* VAT and and shipping costs not included. Errors and price changes excepted
